{"altmetric_id":15103226,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":1,"unique_users":["HealthEconBot"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["588931371162191"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa6173cf058f61000734e","authors":["Alessandro Curto","Katelijne van de Vooren","Livio Garattini"],"doi":"10.1007\/s10198-016-0863-5","first_seen_on":"2016-12-27T20:32:28+00:00","funders":["niehs"],"issns":["1618-7601"],"journal":"The European Journal of Health Economics","last_mentioned_on":1482875848,"links":["http:\/\/link.springer.com\/article\/10.1007%2Fs10198-016-0863-5"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs10198-016-0863-5.pdf","pmid":"28028622","pubdate":"2016-12-27T00:00:00+00:00","publisher":"Springer Berlin Heidelberg","publisher_subjects":[{"name":"Applied Economics","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"subjects":["publichealth","healthservices"],"title":"Market approval for drugs in the EU: time to change direction?","type":"article"},"altmetric_score":{"score":0.5,"score_history":{"1y":0.5,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":7942916,"mean":6.7127945609325,"rank":6021870,"this_scored_higher_than_pct":13,"this_scored_higher_than":1068347,"rank_type":"exact","sample_size":7942916,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":252980,"mean":12.493452618596,"rank":179866,"this_scored_higher_than_pct":17,"this_scored_higher_than":45061,"rank_type":"exact","sample_size":252980,"percentile":17},"this_journal":{"total_number_of_other_articles":612,"mean":3.5580098199673,"rank":465,"this_scored_higher_than_pct":11,"this_scored_higher_than":73,"rank_type":"exact","sample_size":612,"percentile":11},"similar_age_this_journal_3m":{"total_number_of_other_articles":28,"mean":3.0331111111111,"rank":17,"this_scored_higher_than_pct":3,"this_scored_higher_than":1,"rank_type":"exact","sample_size":28,"percentile":3}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/HealthEconBot\/statuses\/813844934147080192","license":"gnip","citation_ids":[15103226],"posted_on":"2016-12-27T20:32:07+00:00","author":{"name":"HealthEconBot","url":"http:\/\/healtheconbot.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2633259384\/1a5f3e7665ed3a78e410c56e50392c40_normal.jpeg","description":"I am a bot. I tweet health economics news, articles and working papers\r\n#HealthEconNews\r\n#HealthEconJA\r\n#HealthEconWP","id_on_source":"HealthEconBot","tweeter_id":"837451189","geo":{"lt":null,"ln":null},"followers":479},"tweet_id":"813844934147080192"}],"facebook":[{"title":"Market approval for drugs in the EU: time to change direction?","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1172368819485107&id=588931371162191","license":"public","citation_ids":[15103226],"posted_on":"2016-12-27T21:57:28+00:00","summary":"#HealthEconJA Market approval for drugs in the EU: time to change direction?","author":{"name":"Healtheconbot","url":"https:\/\/www.facebook.com\/588931371162191","facebook_wall_name":"Healtheconbot","image":"https:\/\/graph.facebook.com\/588931371162191\/picture","id_on_source":"588931371162191"}},{"title":"Market approval for drugs in the EU: time to change direction?","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1172311176157538&id=588931371162191","license":"public","citation_ids":[15103226],"posted_on":"2016-12-27T20:32:11+00:00","summary":"#HealthEconJA Market approval for drugs in the EU: time to change direction?","author":{"name":"Healtheconbot","url":"https:\/\/www.facebook.com\/588931371162191","facebook_wall_name":"Healtheconbot","image":"https:\/\/graph.facebook.com\/588931371162191\/picture","id_on_source":"588931371162191"}}]}}